Waters Corp WAT
i
Market dataready · fetched 2026-11-12T02:34:07.116Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.000807622Z
FundamentalsSEC EDGAR · ready · as of 2026-10-03 · fetched 2026-11-12T02:34:06.674127+00:00
Waters Corp options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 501.48 | 44.8% | 7.3% | 453.38 | 29.8% | 4.3% |
| 25Δ | 492.56 | 39.2% | 5.5% | 456.58 | 30.7% | 3.8% |
| 30Δ | 486.91 | 36.6% | 4.5% | 459.79 | 31.6% | 3.3% |
| 35Δ | 482.63 | 35.6% | 3.8% | 462.86 | 31.4% | 2.9% |
| 40Δ | 478.72 | 35.1% | 3.2% | 465.93 | 31.0% | 2.5% |
| 45Δ | 475.41 | 35.5% | 2.8% | 468.99 | 30.7% | 2.1% |
| 50Δ | 472.09 | 35.9% | 2.5% | 471.87 | 30.4% | 1.8% |
| 55Δ | 468.71 | 36.3% | 2.1% | 474.67 | 30.0% | 1.5% |
| 60Δ | 465.19 | 36.5% | 1.8% | 477.47 | 29.6% | 1.2% |
| 65Δ | 461.68 | 36.7% | 1.5% | 480.29 | 29.2% | 1.0% |
| 70Δ | 457.41 | 37.9% | 1.3% | 483.32 | 28.7% | 0.8% |
| 75Δ | 452.45 | 39.9% | 1.1% | 486.35 | 28.1% | 0.6% |
| 80Δ | 446.16 | 42.7% | 0.9% | 489.38 | 27.6% | 0.4% |
20Δ
- Pseudo strike
- 501.48
- IV
- 44.8%
- B/E move
- 7.3%
- Pseudo strike
- 453.38
- IV
- 29.8%
- B/E move
- 4.3%
25Δ
- Pseudo strike
- 492.56
- IV
- 39.2%
- B/E move
- 5.5%
- Pseudo strike
- 456.58
- IV
- 30.7%
- B/E move
- 3.8%
30Δ
- Pseudo strike
- 486.91
- IV
- 36.6%
- B/E move
- 4.5%
- Pseudo strike
- 459.79
- IV
- 31.6%
- B/E move
- 3.3%
35Δ
- Pseudo strike
- 482.63
- IV
- 35.6%
- B/E move
- 3.8%
- Pseudo strike
- 462.86
- IV
- 31.4%
- B/E move
- 2.9%
40Δ
- Pseudo strike
- 478.72
- IV
- 35.1%
- B/E move
- 3.2%
- Pseudo strike
- 465.93
- IV
- 31.0%
- B/E move
- 2.5%
45Δ
- Pseudo strike
- 475.41
- IV
- 35.5%
- B/E move
- 2.8%
- Pseudo strike
- 468.99
- IV
- 30.7%
- B/E move
- 2.1%
50Δ
- Pseudo strike
- 472.09
- IV
- 35.9%
- B/E move
- 2.5%
- Pseudo strike
- 471.87
- IV
- 30.4%
- B/E move
- 1.8%
55Δ
- Pseudo strike
- 468.71
- IV
- 36.3%
- B/E move
- 2.1%
- Pseudo strike
- 474.67
- IV
- 30.0%
- B/E move
- 1.5%
60Δ
- Pseudo strike
- 465.19
- IV
- 36.5%
- B/E move
- 1.8%
- Pseudo strike
- 477.47
- IV
- 29.6%
- B/E move
- 1.2%
65Δ
- Pseudo strike
- 461.68
- IV
- 36.7%
- B/E move
- 1.5%
- Pseudo strike
- 480.29
- IV
- 29.2%
- B/E move
- 1.0%
70Δ
- Pseudo strike
- 457.41
- IV
- 37.9%
- B/E move
- 1.3%
- Pseudo strike
- 483.32
- IV
- 28.7%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 452.45
- IV
- 39.9%
- B/E move
- 1.1%
- Pseudo strike
- 486.35
- IV
- 28.1%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 446.16
- IV
- 42.7%
- B/E move
- 0.9%
- Pseudo strike
- 489.38
- IV
- 27.6%
- B/E move
- 0.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 32.17% | |
| 31.08% | |
| 32.74% | |
| 34.09% | |
| 34.57% | |
| 38.11% | |
| 33.02% | |
| 34.46% | |
| 32.75% | |
| 32.51% | |
| 31.23% | |
| 30.14% | |
| 31.35% | |
| 31.89% | |
| 31.09% | |
| 31.45% | |
| 30.62% | |
| 33.90% | |
| 33.55% | |
| 34.59% | |
| 32.82% | |
| 34.17% | |
| 36.20% | |
| 35.59% | |
| 34.95% | |
| 32.20% | |
| 32.17% | |
| 31.79% | |
| 32.27% | |
| 32.04% | |
| 31.42% | |
| 31.37% | |
| 31.48% | |
| 32.39% | |
| 33.68% | |
| 32.70% | |
| 32.68% | |
| 33.09% | |
| 33.35% | |
| 34.08% | |
| 33.80% | |
| 35.85% | |
| 36.65% | |
| 37.16% | |
| 38.98% | |
| 35.34% | |
| 35.61% | |
| 35.86% | |
| 34.91% | |
| 36.17% | |
| 36.59% | |
| 37.17% | |
| 36.58% | |
| 36.89% | |
| 36.52% | |
| 40.84% |
Diagnostics & Research
WGS
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
More →XGN
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The…
More →A
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global…
More →ADPT
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is…
More →BLLN
Description unavailable
More →CDNA
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
More →